A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.
about
The cost of biologics for psoriasis is increasingCost-of-illness in psoriasis: comparing inpatient and outpatient therapy.The Budget Impact of Biosimilar Infliximab (Remsima®) for the Treatment of Autoimmune Diseases in Five European CountriesAdministration costs of intravenous biologic drugs for rheumatoid arthritis.Long-Term Cost-Effectiveness Analysis of Etanercept and Adalimumab for Plaque Psoriasis not Associated with Arthritis.The costs of psoriasis medications.Evaluation of psoriasis patients' attitudes toward benefit-risk and therapeutic trade-offs in their choice of treatments.Treatment patterns and therapy effectiveness in psoriasis patients initiating biologic therapy in England.Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study.Treating moderate to severe psoriasis - best use of biologics.The economic burden of psoriasis: a systematic literature review.The cost-effectiveness of ustekinumab for moderate-to-severe psoriasis.Apremilast for the Treatment of Moderate to Severe Plaque Psoriasis: A Critique of the Evidence.Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysis.High burden of hospital resource utilization in patients with hidradenitis suppurativa in England: a retrospective cohort study using hospital episode statistics.Work productivity and healthcare resource utilization outcomes for patients on etanercept for moderate-to-severe plaque psoriasis: results from a 1-year, multicentre, open-label, single-arm study in a clinical setting.Rethinking costs of psoriasis: 10% of patients account for nearly 40% of healthcare expenditures among enrollees with psoriasis in a U.S. health plan.Health economics and the modern management of psoriasis.Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres.Psoriasis: an evidence-based update. Report of the 9th evidenced based update meeting, 12 May 2011, Loughborough, UK.Comparing preferences for outcomes of psoriasis treatments among patients and dermatologists in the U.K.: results from a discrete-choice experiment.
P2860
Q34973745-AB844D5C-E807-4257-881C-A961BC2B4BEFQ35032509-8B360497-ABB2-486D-BA52-C49421D061B1Q36059239-7ACE96F9-D2AB-4760-B632-BE9CC9F4F03DQ37301258-38A91F18-6B3B-4C0F-B40D-DEDC52607C4BQ37468351-CEED42B7-A3D6-4B21-A282-1D1667F3A104Q37468355-CCA5B7D9-EFCF-44A6-832A-2317A7F143BBQ37682855-4E778C95-FD0E-4134-B724-B21ABF19B1E4Q38075573-BBABEAE7-9922-421C-9FC5-8928A60087EAQ38095548-8F2AA205-073D-4CD3-873B-5C9C544F9A1DQ38174153-7DE31869-C9C4-479F-B438-FE9A6FF90269Q38232792-68A1D27D-B9A5-4FCF-886F-6B0096AD5342Q38612964-04110528-9354-4864-A92E-656DF11F1765Q38714712-B73F5F83-E0F7-412F-B31B-F43FD26B922FQ39070719-70DD2FA3-89F8-4D5A-BE0D-68D740F5D9C2Q39480879-D0471022-FE7E-491A-BBBD-9C647C10BF1BQ42662607-9D5943E5-8984-4AA9-8C1B-D73C9DAD8CDFQ45972851-3BCE1911-1502-44D8-8DE6-DEB431F1D9E5Q46788607-6A4E92AE-3FC9-4F58-9D4E-7A033260764FQ48076350-0B23FE86-B690-4C52-8646-3943DE054B8EQ50973080-F24E4722-F047-4813-9494-F01362CA36A1Q53154640-12B95D30-3DA7-4713-9129-2671FBC9437B
P2860
A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
A retrospective cohort study o ...... moderate to severe psoriasis.
@en
A retrospective cohort study o ...... moderate to severe psoriasis.
@nl
type
label
A retrospective cohort study o ...... moderate to severe psoriasis.
@en
A retrospective cohort study o ...... moderate to severe psoriasis.
@nl
prefLabel
A retrospective cohort study o ...... moderate to severe psoriasis.
@en
A retrospective cohort study o ...... moderate to severe psoriasis.
@nl
P2093
P1476
A retrospective cohort study o ...... h moderate to severe psoriasis
@en
P2093
P304
P356
10.1111/J.1365-2133.2010.09944.X
P407
P577
2010-10-01T00:00:00Z